CRISPR Therapeutics AG (CRSP)
51.42
-2.84
(-5.24%)
USD |
NASDAQ |
Oct 30, 16:00
51.38
-0.04
(-0.07%)
After-Hours: 20:00
CRISPR Therapeutics Cash and Short Term Investments (Annual) : 1.983B for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 1.983B |
| December 31, 2024 | 1.904B |
| December 31, 2023 | 1.694B |
| December 31, 2022 | 1.815B |
| December 31, 2021 | 2.379B |
| December 31, 2020 | 1.690B |
| Date | Value |
|---|---|
| December 31, 2019 | 943.77M |
| December 31, 2018 | 456.65M |
| December 31, 2017 | 239.76M |
| December 31, 2016 | 315.52M |
| December 31, 2015 | 155.96M |
| December 31, 2014 | 0.945M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Vertex Pharmaceuticals, Inc. | 6.611B |
| Basilea Pharmaceutica AG | 204.91M |
| Santhera Pharmaceuticals Holding AG | 28.32M |
| BeOne Medicines Ltd. | 4.589B |
| Intellia Therapeutics, Inc. | 449.88M |